Solid Biosciences Inc.
SLDB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001707502
No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Solid Biosciences Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 36 | 37 | +1 |
| Shares | 16.3M | 16.2M | −170.4K (−1.0%) |
| Value | $85.6M | $40.7M | −$44.9M (−52.4%) |
New holders (3)
Institutions that held Solid Biosciences Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 1,488 | $3.75K | 0.00% |
| Qube Research & Technologies Ltd | 1 | $3 | 0.00% |
| Simplex Trading, LLC | 27 | $0 | 0.00% |
Sold out (2)
Institutions that held Solid Biosciences Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| CIBC Asset Management Inc | 12,083 | $63.3K |
| Baker Avenue Asset Management, LP | 66 | $346 |